Ingelheim, Germany

Erhard Fischer

This inventor holds 3 USPTO granted patents and 2 published patent applications, plus 3 CIPO patents. Top assignee: Chemische Fabrik Budenheim Kg. Active years: 2010-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Erhard Fischer. Retrieved from https://idiyas.com/inventor/erhard-fischer-l9cop40w

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3 

% Patents Active = 66.7


Average Co-Inventor Count = 4.1

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2010-2025

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Erhard Fischer: Innovator in Pharmaceutical Powder Technology

Introduction: Erhard Fischer, based in Ingelheim, Germany, is a notable inventor with a focus on dicalcium phosphate anhydride powder, which holds significant relevance in the pharmaceutical industry. With two patents to his name, Fischer's work showcases the intersection of innovation and practical application in pharmaceutical preparations.

Latest Patents: Erhard Fischer's latest patents revolve around the formulation and use of dicalcium phosphate anhydride powder. One of his notable inventions specifies powder wherein at least 50% by weight is characterized by a grain size of 45 to 150 µm, with no more than 50% less than 45 µm and a maximum of 5% exceeding 150 µm. This specific powder composition achieves a bulk density of 1000 to 1500 g/l and a specific surface area of less than 5 m²/g, making it suitable for direct tableting and capsule filling of various pharmaceutical preparations. A parallel patent also emphasizes the same powder characteristics with slightly varying bulk densities and surface areas but maintains its intended application in direct tablet or capsule formulations.

Career Highlights: Erhard Fischer is associated with Chemische Fabrik Budenheim KG, a company renowned for its contributions to chemical and pharmaceutical product development. His career has been marked by a dedication to enhancing the processes involved in pharmaceutical drug formulation through innovative powder technology.

Collaborations: In his professional journey, Fischer has collaborated with respected colleagues, including Gerhard Scheuer and Jurgen Meven. These collaborations have likely contributed to his patent innovations and the advancement of procedures within the company.

Conclusion: Erhard Fischer stands out as a key figure in the field of pharmaceutical innovations, particularly in the domain of dicalcium phosphate anhydride powder technology. His patents reflect a commitment to advancing pharmaceutical preparations, positioning him as a valuable contributor to the industry. Through his work at Chemische Fabrik Budenheim KG and collaborative efforts, Fischer's inventions continue to impact pharmaceutical applications positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…